Evidence map›Paper›PMID 11527718›Full record

ArticleBioorganic & medicinal chemistry letters2001

Synthesis and purine receptor affinity of 6-oxopurine nucleosides and nucleotides containing (N)-methanocarba-pseudoribose rings.

G Ravi, K Lee, X Ji, H S Kim, K A Soltysiak, V E Marquez, K A Jacobson

Open access · greenAbstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Design and in Vivo Characterization of AJournal of medicinal chemistry · 2019
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

G RaviMolecular Recognition Section, LBC, NIDDK, National Institutes of Health, Bethesda, MD 20892, USA.
K Lee
X Ji
H S Kim
K A Soltysiak
V E Marquez
K A Jacobson
National Institutes of Health · USNational Cancer Institute · US

Funding

Drugs that Act at Adenosine ReceptorsZ01DK031117 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI JACOBSON, KENNETH ALAN · 1991 to 2008
$854k
Intramural NIH HHS Z01 DK031117
6 · The paper itself

Abstract

6-Oxopurine derivatives containing a northern (N) methanocarba modification (i.e., fused cyclopropane and cyclopentane rings in place of the ribose) were synthesized and the adenosine receptor affinity measured. Guanine or hypoxanthine was coupled at the 7-position, or 1,3-dibutylxanthine was coupled at the 9-position. The pseudoribose ring was also substituted at the 5'-position with an N-methyluronamide or with phosphate groups.

Indexed as

Purinergic P1 Receptor AgonistsCalciumDrug Evaluation, PreclinicalGuanineHL-60 CellsHumansHypoxanthineNucleosidesNucleotidesReceptor, Adenosine A2AReceptor, Adenosine A3Receptors, Purinergic P1Structure-Activity RelationshipCalciumGuanineHypoxanthineNucleosidesNucleotidesPurinergic P1 Receptor AgonistsReceptor, Adenosine A2AReceptor, Adenosine A3Receptors, Purinergic P1

Identifiers

PMID11527718
PMCPMC4955390
OpenAlexW2025205894

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.